Salesforce Inc. (CRM) Stock Analysis — Price Target, Strong Buy Rating & DCF Valuation (2026)

CRM — Salesforce at ~$180 on ~15x forward P/E (down 33% YTD from ~$270) beat Q1 FY2027 (revenue $11.13B +13%, non-GAAP EPS $3.88 vs $3.13 +24%); Agentforce ARR $1.2B (+205% YoY); $50B buyback authorized; but billings +3.6% was weak — organic growth tracking ~10% vs 20%+ historical norm.

CRM Price Target & Rating

CRM's quantitative grade is Strong Buy, with elevated downside risk (CVaR -27.9%), and quality metrics (net margin 19%, ROE 17%). Salesforce Inc. (CRM) trades at $170.92 with a valuation grade of Strong Buy: a trailing P/E of 19.8x at a 38% discount to sector median, net margins of 18.7%, a DCF-implied intrinsic range of $172–$474 suggesting a +89% margin of safety, beta 1.15 (moderate risk profile).

FAIR RANGEPREMIUM BEAR$172.43BULL$474.36 BASE$271 CURRENT$171 MOS vs BASE+58.4% DCF VALUATION RANGE · CRM
  • Valuation: Strong Buy grade — P/E 19.8x — DCF range $172–$474 implies +89% margin of safety
  • Risk: CVaR -27.9% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.15 amplifies broad market moves in both directions
  • Strengths: Size 4.0/5, 19% net margin, 17% ROE dominate the factor profile
  • Catalyst: Q2 FY2027 billings acceleration above 10%; Agentforce AWU crossing 10B; $0.44 dividend ex-date June 11; next earnings September 2
  • Bear catalyst: Billings growth remains below 5%; cRPO growth decelerates below 10%; large customer churn to Microsoft Dynamics; Agentforce fails to cross $2B ARR by FY2028
CRM — Quantitative Snapshot June 2026
RatingStrong Buy
Price$170.92
Why Strong BuyAttractive valuation relative to peers with solid fundamentals
Main riskElevated tail risk — CVaR -27.9% on a one-month horizon
Tail riskCVaR -27.9% over one month at the 95th percentile
DCF range$172–$474 intrinsic range; margin of safety +89%
Best useCore large-cap Technology holding — not a source of diversified sector exposure
Next watchEarnings surprise deceleration trend — monitor next quarter delivery closely
CRM Quantitative Factor Radar Chart Pentagon radar chart showing CRM factor scores: Value 4.5, Quality 3.0, Momentum 3.0, Volatility 3.0, Size 4.0 — each scored on a 1 to 5 scale. VALUE 4.5 QUALITY 3.0 MOMENTUM 3.0 VOLATILITY 3.0 SIZE 4.0
Value
4.5 / 5
Quality
3.0 / 5
Momentum
3.0 / 5
Volatility
3.0 / 5
Size
4.0 / 5
CRM Key Metrics — Salesforce Inc. 2026
MetricValue
Current Price$170.92
P/E Ratio (TTM)19.8x
Forward P/E11.0x
PEG Ratio0.21x
P/S Ratio3.3
EV/EBITDA13.2
Beta1.15
Net Margin18.7%
ROE16.9%
Debt/Equity124.3%
Dividend Yield1.03%
CVaR (95%, 1M)-27.9%
Market Cap$140.0B
Analyst View
Anton Ladnyi, CFA · A.L. Capital Advisory Updated 2026-06-11

CRM — Salesforce at ~$180 on ~15x forward P/E (down 33% YTD from ~$270) beat Q1 FY2027 (revenue $11.13B +13%, non-GAAP EPS $3.88 vs $3.13 +24%); Agentforce ARR $1.2B (+205% YoY); $50B buyback authorized; but billings +3.6% was weak — organic growth tracking ~10% vs 20%+ historical norm.

↑ Bull Case
  • Agentforce ARR $1.2B (+205% YoY); combined AI + Data 360 ARR $3.4B (+200%+); 3.8B Agentic Work Units delivered — monetisation inflecting from seats to usage
  • Non-GAAP EPS $3.88 vs $3.13 consensus (+24% beat); non-GAAP operating margin 34.8% — expansion trajectory intact
  • Record $50B share buyback authorization + $25B accelerated repurchase; dividend raised; aggressive capital return at ~15x forward P/E is compelling
  • cRPO $33.6B (+14% YoY); total RPO $67.9B (+11%); revenue guidance raised slightly to $45.8-46.2B
  • Usage-based Agentforce monetisation (per completed work unit) could dramatically expand revenue-per-customer if it scales
  • Agentforce ARR reached $1.2B (+205% YoY) in Q1 FY2027; combined Agentforce + Data Cloud ARR surpassed $3B (+200%+); 3.8B Agentic Work Units delivered — usage-based AI monetization accelerating; FY2026 full-year revenue $41.5B, FY2027 guide >$46B; FIFA World Cup 2026 Official Supporter partnership
↓ Bear Case
  • Billings growth only +3.6% YoY — the forward indicator for revenue acceleration; weak billings suggests new business signings are soft
  • Organic growth ~10% vs 20%+ historical norm; Informatica acquisition contributes ~$428M to subscription revenue — organic growth is lower
  • BofA Underperform rating ($160 price target) citing underwhelming Agentforce monetisation pathways; enterprise AI ROI debate delaying deals
  • Down 33% YTD — stock may be 'cheap' at 15x but the multiple re-rating requires billings acceleration that hasn't materialised
  • Microsoft Dynamics and AI-native CRM alternatives gaining enterprise traction
Catalyst: Billings growth re-accelerates to 15%+ for two consecutive quarters; Agentforce ARR reaches $3B; usage-based revenue exceeds 20% of total
Stop / exit: Billings growth remains below 5%; cRPO growth decelerates below 10%; large customer churn to Microsoft Dynamics; Agentforce fails to cross $2B ARR by FY2028
The model points to a strong buy and the DCF math backs it — there is real margin of safety here, which is rare at this stage of the cycle. The DCF gap is striking — the model sees 89% upside, and market consensus is not pricing it. I watch for the catalyst that closes that gap: an earnings beat that resets forward estimates, a sector re-rating, or a margin inflection. Without a visible catalyst, valuation gaps can stay wide longer than logic suggests they should. If the thesis holds across the next two quarters, I would be comfortable carrying this at a meaningful weight. If not — specifically, if margins disappoint or the earnings beat streak breaks — I would reduce before the market fully reprices.
— Anton Ladnyi, CFA
CRM Earnings History — EPS Surprise Rate 2026
QuarterEPS Est.EPS ActualSurprise
Q2 2026$3.13$3.88+24.1%
Q1 2026$3.05$3.81+24.9%
Q4 2025$2.86$3.25+13.6%
Q3 2025$2.78$2.91+4.7%
$0.00$1.00$2.00$3.00$4.00$5.00 +4.7%+13.6%+24.9%+24.1% Q3'25Q4'25Q1'26Q2'26 BEAT RATE4/4 ESTIMATEBEATMISS EPS ACTUAL vs ESTIMATE · CRM
CRM Forward EPS Consensus Estimates 2026
QuarterEPS Est.YoY EPSAnalysts
Q3 2026$3.27+12.4%41
Q4 2026$3.36+3.2%40
Q1 2027~$3.64-4.5%48
Q2 2027~$3.89+0.3%52
~ Estimated from annual consensus — not a direct analyst survey
$0.00$1.00$2.00$3.00$4.00$5.00 +12%+3%-4%+0% Q3 2026Q4 2026Q1 2027Q2 2027 ESTIMATE TRENDACCELERATING CONSENSUS EPSANALYST RANGEBased on 52 analyst estimates EPS FORWARD ESTIMATES · CRM
CRM Peer Valuation Comparison 2026
TickerP/E (TTM)Fwd P/EBetaCVaR-95Net Margin
CRM19.8x11.0x1.15-27.9%18.7%
MSFT23.6x20.5x1.10-17.0%39.3%
GOOGL27.2x24.6x1.24-10.9%37.9%
META20.7x15.8x1.23-19.4%32.8%
AAPL35.3x30.4x1.09-8.5%27.2%
Hover each scenario for detail · current price $170.92
BEAR$130BASE$210BULL$310 $171 DCF SCENARIO RANGE · CRM
Bear Case
$130
-23.9%
Fwd P/E: 9.2x
5.0 revenue CAGR · 12.0 exit multiple
Base Case
$210
+22.9%
Fwd P/E: 14.8x
11.0 revenue CAGR · 17.0 exit multiple
Bull Case
$310
+81.4%
Fwd P/E: 21.9x
18.0 revenue CAGR · 24.0 exit multiple
Pairwise Correlation Matrix — CRM vs NOW vs WDAY vs SAP vs MSFT 5×5 pairwise correlation matrix showing co-movement between CRM, NOW, WDAY, SAP, MSFT over a trailing 12-month window. CRM NOW WDAY SAP MSFT CRM NOW WDAY SAP MSFT 1.00 0.77 0.75 0.59 0.53 0.77 1.00 0.74 0.61 0.59 0.75 0.74 1.00 0.56 0.48 0.59 0.61 0.56 1.00 0.56 0.53 0.59 0.48 0.56 1.00
4 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.

Is CRM a buy, hold, or sell?

CRM carries a valuation grade of Strong Buy. At a trailing P/E of 19.8, the stock trades at a 38% discount to the Technology sector median of 32.0x. Our discounted cash flow model produces an intrinsic range of $172–$474 — implying a +89% margin of safety at the current price of $170.92. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.

With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 24.1% earnings surprise. Analyst estimate revisions are trending upward.

What are CRM's key risk factors?

With a beta of 1.15, CRM exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -27.9% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.8% of total portfolio loss in the worst 5% of months. Net margins stand at 18.7%. Return on equity of 16.9% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 124%.

Implied volatility of 2.1% is below realized volatility of 59.8%, potentially making options relatively cheap. Insider transactions show net buying of $9.1M over the trailing period, a signal often associated with management confidence. Short interest stands at 8.6% of float, a moderate level.

How does CRM fit in a diversified portfolio?

At typical HENRY portfolio weights — 10–20% of the equity allocation — CRM carries a beta of 1.15, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.

Among closely correlated names, CRM shows the strongest co-movement with NOW (0.77), WDAY (0.75), SAP (0.59). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.77, adding CRM to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.

True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The CRM analysis here is a single node in that larger structure.

Is CRM a buy or sell in 2026?

Salesforce Inc. (CRM) carries a Strong Buy quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $170.92, the DCF midpoint margin of safety is +89% (intrinsic value range: $172 bear – $474 bull). Composite factor score: 3.5/5. Strongest factor: Value (4.5/5). Weakest factor: Quality (3.0/5). Trailing P/E: 19.8x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →

What is the average analyst target price for CRM?

Wall Street consensus target for CRM: $254.99 (+49.2% upside from the current price of $170.92). The analyst target range spans $160.00 (most bearish) to $475.00 (most bullish). Consensus recommendation: Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Strong Buy rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →

How does CRM score on Value, Quality, Momentum, Volatility, and Size?

CRM five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 4.5/5 (strong) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 3.0/5 (neutral) — captures profitability metrics including return on equity, net margin (ROE: 16.9%) and net margin (18.7%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 3.0/5 (neutral) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.0/5 (above average) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.5/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →

What is CRM's tail risk and CVaR?

The 95th-percentile Conditional Value at Risk (CVaR) for CRM on a one-month horizon is -27.9%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 1.15 indicates above-market volatility with amplified drawdown exposure. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →

What is CRM's intrinsic value and DCF price target?

A.L. Capital Advisory's DCF model produces an intrinsic value range of $172 (bear case) to $474 (bull case) for Salesforce Inc. (CRM). At $170.92, the midpoint margin of safety is +89% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

What would trigger a rating upgrade or downgrade for CRM?

Upgrade trigger: Upgrade to Strong Buy on evidence of accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 19.8x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →

Does CRM consistently beat earnings estimates?

CRM has beaten consensus EPS estimates in 12% of tracked quarterly periods — indicating inconsistent delivery. The most recent reported quarter beat consensus by 24.1%. Below-average earnings consistency is a primary headwind to the rating and a key watch item in the quantitative model. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

How does CRM contribute to portfolio risk and diversification?

CRM carries a beta of 1.15 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: NOW (0.77), WDAY (0.75), SAP (0.59). Holding CRM alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →

What quantitative methodology does A.L. Capital Advisory use to analyse CRM?

A.L. Capital Advisory analyses Salesforce Inc. (CRM) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Strong Buy rating for CRM is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →  ·  CVaR & Tail-Risk Methodology →

Stress-Test This View Live

Run CRM in Asset Lens

Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.

Launch Live Analysis →
Anton Ladnyi — Founder & Portfolio Architect, A.L. Capital Advisory, ex-Goldman Sachs, CFA
Anton Ladnyi, CFA
Founder & Portfolio Architect — A.L. Capital Advisory
Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder
Legal Disclaimer & Important Notices

This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-06-11 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Salesforce Inc.

CFA Portfolio Advisory — CRM Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.